Unknown

Dataset Information

0

Effectiveness of Implantable Cardioverter-Defibrillators to Reduce Mortality in Patients With Long QT Syndrome.


ABSTRACT:

Background

The effectiveness of implantable cardioverter-defibrillators (ICDs) on reducing mortality has not been well studied in patients with long QT syndrome (LQTS).

Objectives

This study aimed to assess the survival benefits of ICDs in the overall LQTS population and in subgroups defined by ICD indications.

Methods

This study included 3,035 patients (597 with ICD) from the Rochester LQTS Registry with a QTc ≥470 milliseconds or confirmed LQTS mutation. Using multivariable Cox proportional hazards models, the risk of all-cause mortality, all-cause mortality before age 50 years, and sudden cardiac death (SCD) were estimated as functions of time-dependent ICD therapy. Indication subgroups examined included patients with: 1) nonfatal cardiac arrest; 2) syncope while on beta-blockers; and 3) a QTc ≥500 milliseconds and syncope while off beta-blockers.

Results

During the 118,837 person-years of follow-up, 389 patients died (137 before age 50 years, and 116 experienced SCD). In the entire population, patients with ICDs had a lower risk of death (HR: 0.54; 95% CI: 0.34-0.86), death before age 50 years (HR: 0.29; 95% CI: 0.14-0.61), and SCD (HR: 0.22; 95% CI: 0.09-0.55) than patients without ICDs did. Patients with ICDs also had a lower risk of mortality among the 3 indication subgroups (HR: 0.14; 95% CI: 0.06-0.34; HR: 0.27; 95% CI: 0.10-0.72; and HR: 0.42; 95% CI: 0.19-0.96, respectively).

Conclusions

ICD therapy was associated with a lower risk of all-cause mortality, all-cause mortality before age 50 years, and SCD in the LQTS population, as wells as with a lower risk of all-cause mortality in indication subgroups. This study provides evidence supporting ICD implantation in patients with high-risk LQTS.

SUBMITTER: Wang M 

PROVIDER: S-EPMC8608269 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effectiveness of Implantable Cardioverter-Defibrillators to Reduce Mortality in Patients With Long QT Syndrome.

Wang Meng M   Peterson Derick R DR   Rosero Spencer S   McNitt Scott S   Rich David Q DQ   Seplaki Christopher L CL   Polonsky Bronislava B   Goldenberg Ilan I   Zareba Wojciech W  

Journal of the American College of Cardiology 20211101 21


<h4>Background</h4>The effectiveness of implantable cardioverter-defibrillators (ICDs) on reducing mortality has not been well studied in patients with long QT syndrome (LQTS).<h4>Objectives</h4>This study aimed to assess the survival benefits of ICDs in the overall LQTS population and in subgroups defined by ICD indications.<h4>Methods</h4>This study included 3,035 patients (597 with ICD) from the Rochester LQTS Registry with a QTc ≥470 milliseconds or confirmed LQTS mutation. Using multivariab  ...[more]

Similar Datasets

| S-EPMC7792399 | biostudies-literature
| S-EPMC6365807 | biostudies-literature
| S-EPMC6816602 | biostudies-literature
| S-EPMC4712727 | biostudies-literature
| S-EPMC7076170 | biostudies-literature
| S-EPMC3526187 | biostudies-literature
| S-EPMC9156377 | biostudies-literature
| S-EPMC7429066 | biostudies-literature
| S-EPMC4103758 | biostudies-literature
| S-EPMC4336541 | biostudies-literature